Öppna denna publikation i ny flik eller fönster >>Genetics and Diabetes Research Unit, Department of Clinical Sciences Malmö, Lund University, Malmö, Sweden.
Örebro universitet, Institutionen för medicinska vetenskaper. Region Örebro län. University Health Care Research Centre.
Department of Obstetrics and Gynaecology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Sahlgrenska University Hospital, Gothenburg, Sweden.
Department of Women's and Children's Health, Uppsala University, Akademiska Sjukhuset, Uppsala, Sweden.
Department of Obstetrics and Gynaecology, Skåne University Hospital, Department of Clinical Sciences Lund, Lund University, Lund, Sweden; Department of Clinical Sciences Lund, Lund University, Lund, Sweden.
Department of Women's and Children's Health, Uppsala University, Akademiska Sjukhuset, Uppsala, Sweden.
Department of Obstetrics and Gynaecology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Sahlgrenska University Hospital, Gothenburg, Sweden.
Department of Obstetrics and Gynaecology Södersjukhuset, Karolinska Institute, Stockholm, Sweden.
Department of Clinical Science and Education, Karolinska Institutet, Stockholm, Sweden; Department of Medicine, Clinical Epidemiology, Karolinska Institutet and Sachsska Childrens' and Youth Hospital, Stockholm, Sweden.
Department of Obstetrics and Gynaecology, Hospital Södersjukhuset, Stockholm, Umeå University, Stockholm, Sweden.
Department of Endocrinology and Diabetology, Hospital Södersjukhuset, Stockholm University, Stockholm, Sweden.
Örebro universitet, Institutionen för hälsovetenskaper. Region Örebro län. University Health Care Research Centre.
Örebro universitet, Institutionen för medicinska vetenskaper. Örebro universitet, Institutionen för hälsovetenskaper. Department of Obstetrics and Gynaecology, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.
Visa övriga...
2025 (Engelska)Ingår i: British Journal of Obstetrics and Gynecology, ISSN 1470-0328, E-ISSN 1471-0528Artikel i tidskrift (Refereegranskat) Epub ahead of print
Abstract [en]
OBJECTIVE: To estimate the effect on healthcare resource use after introducing the World Health Organization diagnostic criteria (WHO-2013) for gestational diabetes mellitus (GDM) compared to former criteria in Sweden (SWE-GDM). DESIGN: A cost-analysis alongside the Changing Diagnostic Criteria for Gestational Diabetes (CDC4G) randomised controlled trial.
SETTING: Sweden, with risk-factor based screening for GDM. POPULATION: 47 080 pregnant women and their infants. METHODS: A register-based cost-analysis from a healthcare perspective alongside a stepped-wedge cluster RCT of switching from SWE-GDM to WHO-2013 criteria in 2018. Analyses were made on the population level and repeated in the subgroup affected by the intervention, that is, those with plasma glucose values between SWE-GDM and WHO-2013 criteria. Sensitivity analysis by bootstrapping was performed.
MAIN OUTCOME MEASURES: Estimated costs for obstetric surveillance (including GDM-management), delivery and neonatal healthcare until 28 days postpartum. RESULTS: On a population level, the WHO-2013 criteria were associated with increased costs of obstetric surveillance (adjusted mean [bootstrap confidence interval]) €94.0 [24.5-169.1], delivery care €20.4 [-33.5 to 75.4] and neonatal care €331.0 [75.1-589.0] per pregnancy, and in the affected subgroup €606.9 [377.7-872.4], €348.5 [126.0-542.0] and €129.3 [-559.0 to 980.9] respectively.
CONCLUSIONS: Implementation of the WHO-2013 criteria in Sweden was associated with increased costs for obstetric surveillance and delivery on a population level, driven by the affected subgroup. The increased costs for neonatal care were associated with large uncertainty. A detailed understanding of the changes in resource use can guide decisions to mitigate cost increases.
Ort, förlag, år, upplaga, sidor
Wiley-Blackwell Publishing Inc., 2025
Nyckelord
cost analysis, diagnostic criteria, gestational diabetes mellitus, healthcare resource use
Nationell ämneskategori
Gynekologi, obstetrik och reproduktionsmedicin
Identifikatorer
urn:nbn:se:oru:diva-123625 (URN)10.1111/1471-0528.18364 (DOI)001567613500001 ()40931348 (PubMedID)2-s2.0-105015466951 (Scopus ID)
Forskningsfinansiär
Vetenskapsrådet, 2018-00470Stiftelsen Mary von Sydows, född Wijk, donationsfond, 1017Stiftelsen Mary von Sydows, född Wijk, donationsfond, 4917Stiftelsen Mary von Sydows, född Wijk, donationsfond, 2618Stiftelsen Mary von Sydows, född Wijk, donationsfond, 3718Nyckelfonden, OLL-597601Region Örebro län, OLL-693551Region Örebro län, OLL-786911Region StockholmRegion Västmanland, LTV-966501Region Skåne
Anmärkning
Funding Agencies:
This work was supported by Swedish Research Council, Clinical therapy research (2018-00470), Mrs Mary von Sydows, born Wijk (numbers 1017, 4917, 2618 and 3718), Nyckelfonden Region Örebro County (OLL-597601), Region Örebro County Research committee (OLL-693551, OLL-786911), Regional Research committee Uppsala-Örebro (RFR-749241), Region Stockholm County, the Centre of Clinical Research, Västmanland County Council (LTV-966501) and grants from the Swedish state under the agreement between the Swedish government and the county councils, the ALF-agreement (GBG-823211, ALFGBG-932692, OLL-930268), Skåne University Hospital, and the Skåne County Council Research and Development Foundation (REGSKANE-622891).
2025-09-122025-09-122026-01-23Bibliografiskt granskad